Researchers recently discovered that an experimental cancer vaccine offers “a promising approach” to preventing pancreatic and colorectal cancers from coming back after treatment. In a recent press release, UCLA Health announced that in a phase 1 clinical trial, which was backed by the UCLA Health Jonsson Comprehensive Cancer Center, researchers tested a cancer vaccine that …
Read more
—
Researchers recently discovered that an experimental cancer vaccine offers “a promising approach” to preventing pancreatic and colorectal cancers from coming back after treatment.
In a recent press release, UCLA Health announced that in a phase 1 clinical trial, which was backed by the UCLA Health Jonsson Comprehensive Cancer Center, researchers tested a cancer vaccine that can “trigger powerful and lasting immune responses and may help prevent or delay cancer recurrence in high-risk patients whose tumors are driven by KRAS mutations.” The vaccine was tested on 25 patients who had received treatment for colorectal cancer and pancreatic cancer.
